STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2287 by analyst upside · 2026-06-27
DOCS
Doximity, Inc.
Healthcare · Market Cap $4B · P/E 20.3x
ANALYST PRICE TARGET
+21.7%
implied upside to consensus target
Current Price $20.88
Consensus Target $25.42
Bull Target $42.0
Bear Target $18.0
Analysts Covering 19
ANALYST CONSENSUS — BUY
Strong Buy
4
Buy
11
Hold
4
Sell
0
52-Week Low $17.15
52-Week High $76.51
YTD Return -51.8%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) 20.3x
Forward P/E 13.1x
EPS (TTM) $1.03
PEG Ratio 0.59
Dividend Yield N/A
Revenue (TTM) $645M
Profit Margin 30.4%
52-WEEK RANGE
52-Week Low $17.15
52-Week High $76.51
Current Price $20.88
Bear Target $18.0
Bull Target $42.0
● Now $20.88 ● Target $25.42
TRADING DATA
Avg Volume 4.0M
YTD Return -51.8%
Analyst Count 19
Consensus Buy
Upside to Target +21.7%
Last Updated 2026-06-27

ANALYST SUMMARY

Doximity, Inc. (DOCS) is currently trading at $20.88 with a Wall Street consensus price target of $25.42, implying potential upside of 21.7% over the next 12 months. 19 analysts currently cover DOCS, with a consensus rating of Buy — 79% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $42.0, while the most cautious has a target of $18.0.

DOCS operates in the Healthcare sector with a market capitalisation of $4B. The stock is down 51.8% year-to-date and is currently trading near the lower end of its 52-week range of $17.15 – $76.51.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for DOCS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Goldman Sachs — Reiterated
Neutral → Neutral 2026-05-15 Building track record
Barclays ↓ Downgrade
Overweight → Equal-Weight 2026-05-15 Building track record
Leerink Partners — Reiterated
Outperform → Outperform 2026-05-14 29% win rate (7 calls)
Jefferies ↓ Downgrade
Buy → Hold 2026-05-14 50% win rate (6 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2026-05-14 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-05-14 43% win rate (7 calls)
Goldman Sachs — Reiterated
Neutral → Neutral 2026-05-14 Building track record
Truist Securities reit
Hold → Hold 2026-05-14 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →